Skip to main content
. 2020 Nov 19;10(11):290. doi: 10.3390/life10110290
HPV Human papillomavirus
Pap test Papanicolaou test
Lr Lower risk
Hr High-risk
ASC-US Atypical squamous cells of undetermined significance
NPV Negative predictive value
LEEP Loop electrosurgical excision procedure
RFLP Restriction fragment length polymorphism
TMA Transcription mediated amplification
NASBA Nucleic-acid sequenced based amplification
VALGENT Validation of HPV Genotyping Tests
HC2 Hybrid Capture 2
EIA Enzyme Immunoassay
US FDA United States Food and Drug Administration
LMNX Luminex
IARC International Agency for Research on Cancer
LBC Liquid-Based Cytology
PCR Polymerase Chain Reaction